Page last updated: 2024-08-21

alpha-aminopyridine and Hypoglycemia

alpha-aminopyridine has been researched along with Hypoglycemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agafonova, N; Cruz, M; Dodds, M; Katz, L; Kaur, P; Kewalramani, R; Manamley, N; Mudaliar, S; Pellacani, A; Raskin, P; Sierra-Johnson, J; Snyder, WJ	1

Trials

1 trial(s) available for alpha-aminopyridine and Hypoglycemia

Article	Year
AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes. Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:2 Topics: Adult; Aminopyridines; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drugs, Investigational; Enzyme Activators; Follow-Up Studies; Glucokinase; Glycated Hemoglobin; Headache; Humans; Hyperglycemia; Hypertriglyceridemia; Hypoglycemia; Hypoglycemic Agents; Incidence; Least-Squares Analysis; Postprandial Period; Thiadiazoles; Triglycerides	2016

Article

Year

AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes.

Diabetes, obesity & metabolism, 2016, Volume: 18, Issue:2

Topics: Adult; Aminopyridines; Blood Glucose; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drugs, Investigational; Enzyme Activators; Follow-Up Studies; Glucokinase; Glycated Hemoglobin; Headache; Humans; Hyperglycemia; Hypertriglyceridemia; Hypoglycemia; Hypoglycemic Agents; Incidence; Least-Squares Analysis; Postprandial Period; Thiadiazoles; Triglycerides

2016